Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.93 USD | +0.34% |
|
-0.47% | -13.65% |
Jul. 01 | Nature's Sunshine Products, Inc.(NasdaqCM:NATR) added to Russell 3000 Growth Index | CI |
Jul. 01 | Nature's Sunshine Products, Inc.(NasdaqCM:NATR) added to Russell Microcap Growth Index | CI |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Capitalization 1 | 293.9 | 365.6 | 159.5 | 329.8 | 279.6 | - |
Enterprise Value (EV) 1 | 293.9 | 282.1 | 100.6 | 247.4 | 189.4 | 180.6 |
P/E ratio | 14 x | 13 x | -416 x | 22.5 x | 20.7 x | 17.4 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.76 x | 0.82 x | 0.38 x | 0.74 x | 0.61 x | 0.58 x |
EV / Revenue | 0.76 x | 0.64 x | 0.24 x | 0.56 x | 0.42 x | 0.37 x |
EV / EBITDA | - | 5.71 x | 3.14 x | 6.12 x | 4.5 x | 3.89 x |
EV / FCF | - | 34.9 x | -9.12 x | 8.27 x | 7.67 x | 6.27 x |
FCF Yield | - | 2.87% | -11% | 12.1% | 13% | 15.9% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 19,658 | 19,761 | 19,167 | 19,075 | 18,730 | - |
Reference price 2 | 14.95 | 18.50 | 8.320 | 17.29 | 14.93 | 14.93 |
Announcement Date | 3/10/21 | 3/8/22 | 3/15/23 | 3/12/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | 385.2 | 444.1 | 421.9 | 445.3 | 455.8 | 483.1 |
EBITDA 1 | - | 49.42 | 32.03 | 40.42 | 42.1 | 46.4 |
EBIT 1 | - | 34.53 | 18.1 | 23.71 | 24.1 | 27.5 |
Operating Margin | - | 7.77% | 4.29% | 5.32% | 5.29% | 5.69% |
Earnings before Tax (EBT) 1 | - | - | - | - | 24.1 | 27.5 |
Net income 1 | - | - | -0.39 | 15.08 | 13.8 | 16.5 |
Net margin | - | - | -0.09% | 3.39% | 3.03% | 3.42% |
EPS 2 | 1.070 | 1.420 | -0.0200 | 0.7700 | 0.7200 | 0.8600 |
Free Cash Flow 1 | - | 8.084 | -11.04 | 29.91 | 24.7 | 28.8 |
FCF margin | - | 1.82% | -2.62% | 6.72% | 5.42% | 5.96% |
FCF Conversion (EBITDA) | - | 16.36% | - | 74% | 58.67% | 62.07% |
FCF Conversion (Net income) | - | - | - | 198.41% | 178.99% | 174.55% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/10/21 | 3/8/22 | 3/15/23 | 3/12/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 117.9 | 110.5 | 104.2 | 104.5 | 102.7 | 108.6 | 116.5 | 111.2 | 108.9 | 111 | 112.3 | 116.2 | 116.3 | 117.7 | 119 |
EBITDA 1 | 11.57 | 8.183 | 8.98 | 6.836 | 8.031 | 9.133 | 11.31 | 10.25 | 9.729 | 9.153 | 10.2 | 10.3 | 12.4 | 10.1 | 11.3 |
EBIT 1 | 7.912 | 4.616 | 5.755 | 5.012 | 4.151 | 5.27 | 7.037 | 5.832 | 5.573 | 4.624 | 5.8 | 5.7 | 8 | 5.4 | 6.6 |
Operating Margin | 6.71% | 4.18% | 5.53% | 4.8% | 4.04% | 4.85% | 6.04% | 5.24% | 5.12% | 4.17% | 5.16% | 4.91% | 6.88% | 4.59% | 5.55% |
Earnings before Tax (EBT) 1 | 6.985 | 0.995 | 5.313 | 2.731 | 6.176 | - | - | - | 7.661 | 4.655 | 5.8 | 5.7 | 8 | 5.4 | 6.6 |
Net income 1 | 13.44 | -2.95 | 0.516 | 0.09 | 1.954 | 0.86 | 2.422 | 2.832 | 8.962 | 2.321 | 3.4 | 3.3 | 4.8 | 3.3 | 4 |
Net margin | 11.39% | -2.67% | 0.5% | 0.09% | 1.9% | 0.79% | 2.08% | 2.55% | 8.23% | 2.09% | 3.03% | 2.84% | 4.13% | 2.8% | 3.36% |
EPS 2 | 0.6700 | -0.1500 | 0.0300 | 0.004600 | 0.1000 | 0.0400 | 0.1200 | 0.1500 | 0.4600 | 0.1200 | 0.1800 | 0.1700 | 0.2500 | 0.1700 | 0.2100 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/8/22 | 5/5/22 | 8/9/22 | 11/3/22 | 3/15/23 | 5/9/23 | 8/9/23 | 11/7/23 | 3/12/24 | 5/7/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | - | 83.5 | 58.9 | 82.4 | 90.2 | 99 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | 8.08 | -11 | 29.9 | 24.7 | 28.8 |
ROE (net income / shareholders' equity) | - | 17.9% | - | 6.72% | 8.7% | 10.5% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | - | 6.67 | 7.63 | 10.5 | 9.7 | 9.7 |
Capex / Sales | - | 1.5% | 1.81% | 2.35% | 2.13% | 2.01% |
Announcement Date | 3/10/21 | 3/8/22 | 3/15/23 | 3/12/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.65% | 280M | |
+12.62% | 8.08B | |
+6.62% | 7.71B | |
-21.58% | 4.62B | |
-9.19% | 3.6B | |
-22.84% | 3.07B | |
-16.04% | 1.15B | |
-29.82% | 1.07B | |
-4.25% | 924M | |
-17.07% | 847M |
- Stock Market
- Equities
- NATR Stock
- Financials Nature's Sunshine Products, Inc.